Alastair Kent

28.5k total citations
40 papers, 791 citations indexed

About

Alastair Kent is a scholar working on Genetics, Public Health, Environmental and Occupational Health and Physiology. According to data from OpenAlex, Alastair Kent has authored 40 papers receiving a total of 791 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Genetics, 10 papers in Public Health, Environmental and Occupational Health and 10 papers in Physiology. Recurrent topics in Alastair Kent's work include Genomics and Rare Diseases (14 papers), Biomedical Ethics and Regulation (10 papers) and BRCA gene mutations in cancer (10 papers). Alastair Kent is often cited by papers focused on Genomics and Rare Diseases (14 papers), Biomedical Ethics and Regulation (10 papers) and BRCA gene mutations in cancer (10 papers). Alastair Kent collaborates with scholars based in United Kingdom, United States and Italy. Alastair Kent's co-authors include Heather Skirton, Celine Lewis, Domenico Coviello, Adam Hutchings, Martina Garau, Claude Schmitt, Jon Sussex, Susan Wallace, Jane Kaye and Christopher McCabe and has published in prestigious journals such as Science, SHILAP Revista de lepidopterología and Science Translational Medicine.

In The Last Decade

Alastair Kent

40 papers receiving 763 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alastair Kent United Kingdom 16 301 198 188 175 163 40 791
Emmanuelle Rial‐Sebbag France 14 292 1.0× 401 2.0× 316 1.7× 93 0.5× 221 1.4× 70 886
W. Andrew Faucett United States 17 622 2.1× 222 1.1× 100 0.5× 101 0.6× 300 1.8× 29 1.2k
Gail Javitt United States 15 548 1.8× 280 1.4× 177 0.9× 59 0.3× 130 0.8× 34 927
Stephen C. Groft United States 19 561 1.9× 184 0.9× 104 0.6× 170 1.0× 339 2.1× 41 1.4k
Ma’n H. Zawati Canada 16 322 1.1× 475 2.4× 202 1.1× 68 0.4× 104 0.6× 86 813
Béatrice Godard Canada 20 632 2.1× 522 2.6× 212 1.1× 77 0.4× 187 1.1× 75 1.3k
Katherine Kolor United States 16 508 1.7× 207 1.0× 55 0.3× 113 0.6× 215 1.3× 28 957
Anya E. R. Prince United States 15 310 1.0× 207 1.0× 82 0.4× 70 0.4× 82 0.5× 53 644
Carla van El Netherlands 19 903 3.0× 427 2.2× 212 1.1× 117 0.7× 312 1.9× 58 1.7k
Tiffany Boughtwood Australia 11 342 1.1× 189 1.0× 48 0.3× 123 0.7× 117 0.7× 29 611

Countries citing papers authored by Alastair Kent

Since Specialization
Citations

This map shows the geographic impact of Alastair Kent's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alastair Kent with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alastair Kent more than expected).

Fields of papers citing papers by Alastair Kent

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alastair Kent. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alastair Kent. The network helps show where Alastair Kent may publish in the future.

Co-authorship network of co-authors of Alastair Kent

This figure shows the co-authorship network connecting the top 25 collaborators of Alastair Kent. A scholar is included among the top collaborators of Alastair Kent based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alastair Kent. Alastair Kent is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Horgan, Denis, Stefania Boccia, Maurizio Genuardi, et al.. (2020). Time for Change? The Why, What and How of Promoting Innovation to Tackle Rare Diseases – Is It Time to Update the EU’s Orphan Regulation? And if so, What Should be Changed?. SHILAP Revista de lepidopterología. 5(2). 1–11. 14 indexed citations
2.
Harris, Tess, Richard Sandford, Olivier Devuyst, et al.. (2017). European ADPKD Forum multidisciplinary position statement on autosomal dominant polycystic kidney disease care. Nephrology Dialysis Transplantation. 33(4). 563–573. 26 indexed citations
3.
Bauer, Gerhard, et al.. (2016). The path to successful commercialization of cell and gene therapies: empowering patient advocates. Cytotherapy. 19(2). 293–298. 14 indexed citations
4.
Facey, Karen, Alı́cia Granados, Gordon Guyatt, et al.. (2014). GENERATING HEALTH TECHNOLOGY ASSESSMENT EVIDENCE FOR RARE DISEASES. International Journal of Technology Assessment in Health Care. 30(4). 416–422. 29 indexed citations
5.
Kaye, Jane, Matthew E. Hurles, Martin Bobrow, et al.. (2014). Managing clinically significant findings in research: the UK10K example. European Journal of Human Genetics. 22(9). 1100–1104. 23 indexed citations
6.
Christianson, Arnold L., R.L. Zimmern, Ulf Kristoffersson, et al.. (2013). Health needs assessment for medical genetic services for congenital disorders in middle- and low-income nations. Journal of Community Genetics. 4(3). 297–308. 9 indexed citations
7.
Sussex, Jon, et al.. (2013). A Pilot Study of Multicriteria Decision Analysis for Valuing Orphan Medicines. Value in Health. 16(8). 1163–1169. 85 indexed citations
8.
Kent, Alastair, et al.. (2011). Participation of patients in the development of advanced therapy medicinal products. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz. 54(7). 839–842. 5 indexed citations
9.
Skirton, Heather, Celine Lewis, Alastair Kent, & Domenico Coviello. (2010). Genetic education and the challenge of genomic medicine: development of core competences to support preparation of health professionals in Europe. European Journal of Human Genetics. 18(9). 972–977. 119 indexed citations
10.
Kent, Alastair, Nancy M. P. King, & Odile Cohen‐Haguenauer. (2010). Toward a Proportionate Regulatory Framework for Gene Transfer: A Patient Group-Led Initiative. Human Gene Therapy. 22(2). 126–134. 3 indexed citations
11.
Kent, Alastair. (2008). Non-invasive prenatal diagnosis: Public and patient perceptions. Seminars in Fetal and Neonatal Medicine. 13(2). 109–112. 11 indexed citations
12.
Foster, Michelle, et al.. (2007). The Michigan Guidelines on Protection Elsewhere. Michigan Journal of International Law. 28(2). 1 indexed citations
13.
Lewis, Celine, et al.. (2007). An assessment of written patient information provided at the genetic clinic and relating to genetic testing in seven European countries. European Journal of Human Genetics. 15(10). 1012–1022. 15 indexed citations
14.
Coviello, Domenico, Heather Skirton, N. Ceratto, Celine Lewis, & Alastair Kent. (2007). Genetic testing and counselling in Europe: health professionals current educational provision, needs assessment and potential strategies for the future. European Journal of Human Genetics. 15(12). 1203–1204. 10 indexed citations
15.
Shepperd, Sasha, Peter Farndon, Sandy Oliver, et al.. (2006). DISCERN-Genetics: quality criteria for information on genetic testing. European Journal of Human Genetics. 14(11). 1179–1188. 23 indexed citations
16.
Parker, Michael D., Richard Ashcroft, Andrew O.M. Wilkie, & Alastair Kent. (2004). Ethical review of research into rare genetic disorders. BMJ. 329(7460). 288–289. 28 indexed citations
17.
Kent, Alastair. (2003). Consent and confidentiality in genetics: whose information is it anyway?. Journal of Medical Ethics. 29(1). 16–18. 20 indexed citations
18.
Kent, Alastair. (2001). Putting the genetics genie back into its bottle. BMJ. 322(7293). 1070.2–1070.2. 1 indexed citations
19.
Kent, Alastair. (1999). The Role of Voluntary Consumer Organisations in Genetic Services in the United Kingdom. Public Health Genomics. 2(4). 156–161. 3 indexed citations
20.
Raeburn, Sandy, et al.. (1997). Genetic services in the United Kingdom.. PubMed. 5 Suppl 2. 188–95. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Emmanuelle Rial‐Sebbag Breakdown of academic impact, for papers by W. Andrew Faucett Breakdown of academic impact, for papers by Gail Javitt Breakdown of academic impact, for papers by Stephen C. Groft Breakdown of academic impact, for papers by Ma’n H. Zawati Breakdown of academic impact, for papers by Béatrice Godard Breakdown of academic impact, for papers by Katherine Kolor Breakdown of academic impact, for papers by Anya E. R. Prince Breakdown of academic impact, for papers by Carla van El Breakdown of academic impact, for papers by Tiffany Boughtwood
Rankless by CCL
2026